Aspa Therapeutics recently hosted a webinar for the Canavan Disease community. Click here to listen to Professor Guangping Gao (left) a pioneer in gene therapy, and the Aspa team describing their clinical development program for Canavan disease. Dr. Gao discovered the gene, the AAV9 vector for delivering the gene,  and developed what has become Aspa's investigational gene therapy program.